Press release

Kyndryl Launches AI-Powered Digital Twin for the Workplace

Built on Microsoft Foundry, Kyndryl’s solution helps enterprises predict, prevent and resolve technology disruptions   NEW YORK, April 9, 2026…

Read More »

VELUX Skylight System Named Sustainable Product of the Year by Green Builder Media

Recognition honors innovation in energy efficiency, daylighting, and healthier home design FORT MILL, S.C., April 9, 2026 /PRNewswire/ — VELUX, the…

Read More »

TEAM GROUP ANNOUNCES ACQUISITION OF A&J VACWORX, EXPANDING INDUSTRIAL SERVICES PLATFORM

AURORA, ON, April 9, 2026 /CNW/ – TEAM Group Inc. (“TEAM Group”), a leading North American provider of integrated industrial…

Read More »

Host City Bids Open for The Games Of The Future 2028 to 2030

Phygital International opens host city bidding, inviting cities to take a leading role in the future of sport as phygital…

Read More »

Privacy and Data Security Litigator Elisabeth Hutchinson Rejoins Shook as Partner in Denver

DENVER, April 9, 2026 /PRNewswire/ — Shook, Hardy & Bacon bolstered its national Chambers-ranked Privacy and Cybersecurity Practice with the addition…

Read More »

CB&I Completes Acquisition of Petrofac Asset Solutions Business

THE WOODLANDS, Texas, April 9, 2026 /PRNewswire/ — CB&I today announced the completion of an asset sale agreement, previously announced on…

Read More »

KLG Business Valuators & Forensic Accountants, LLC, Combines with EisnerAmper

Premier Litigation Support Firm Has Decades of Business Valuation and Forensic Accounting Expertise NEW YORK, April 9, 2026 /PRNewswire/ —…

Read More »

KLG Business Valuators & Forensic Accountants, LLC, Combines with EisnerAmper

Premier Litigation Support Firm Has Decades of Business Valuation and Forensic Accounting Expertise NEW YORK, April 9, 2026 /PRNewswire/ —…

Read More »

Anixa Biosciences to Participate in RedChip’s Biotech Resurgence: Platforms and Pipelines of Today’s Innovators Conference on April 16, 2026

Breast cancer vaccine met primary endpoints and generated protocol-defined immuneresponses in 74% of participants in Phase 1 clinical trial Ovarian…

Read More »

Anixa Biosciences to Participate in RedChip’s Biotech Resurgence: Platforms and Pipelines of Today’s Innovators Conference on April 16, 2026

Breast cancer vaccine met primary endpoints and generated protocol-defined immuneresponses in 74% of participants in Phase 1 clinical trial Ovarian…

Read More »